Comorbidity of schizophrenia and substance abuse: implications for treatment.
Comorbidity of schizophrenia and substance abuse: implications for treatment.
复制标题
精神分裂症和药物滥用的共病：对治疗的影响。
DOI：
10.1037//0022-006x.60.6.845
复制
发表时间：
1992
影响因子：
5.9
通讯作者：
Blanchard,JJ
中科院分区：
文献类型：
--
作者：
Mueser,KT;Bellack,AS;Blanchard,JJ
本文的重点是精神分裂症药物滥用的问题及其治疗方法，以帮助治疗师优化这种双重诊断人群的结果。作者组织了这篇综述，首先描述了有关精神分裂症病程中药物滥用的患病率、评估和影响的研究。其次，他们回顾了药物滥用对精神分裂症患者认知因素影响的研究，并考虑了这些影响对治疗的影响。第三，作者总结了精神分裂症药物滥用患者的治疗原则，回顾了该领域有限的治疗结果研究，并确定了未来研究的途径，以提高现有治疗技术的疗效。（PsycInfo数据库记录(c) 2024 APA，版权所有）
This article focuses on the problems of substance abuse in schizophrenia and its treatments to help therapists optimize the outcome of this dual-diagnosis population. The authors organized this review to first describe research on the prevalence, assessment, and impact of substance abuse on the course of schizophrenia. Second, they review studies on the effects of substance abuse on cognitive factors in schizophrenia and consider the implications of these effects for treatment. Third, the authors summarize the principles of treating substance abusing schizophrenia patients, and review the limited treatment outcome research in this area, and identify avenues for future research that may improve the efficacy of existing treatment technologies.(PsycInfo Database Record (c) 2024 APA, all rights reserved)